| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 352.83B | 363.67B | 350.09B | 333.20B | 325.02B | 298.57B |
| Gross Profit | 32.27B | 34.08B | 31.35B | 28.21B | 28.47B | 26.86B |
| EBITDA | 8.47B | 7.30B | 7.69B | 4.93B | 5.62B | 3.52B |
| Net Income | 5.02B | 5.38B | 4.53B | 3.62B | 3.08B | 1.34B |
Balance Sheet | ||||||
| Total Assets | 96.57B | 96.74B | 90.27B | 92.52B | 81.99B | 78.74B |
| Cash, Cash Equivalents and Short-Term Investments | 2.78B | 1.38B | 2.79B | 2.43B | 2.74B | 2.60B |
| Total Debt | 29.01B | 22.31B | 24.54B | 26.05B | 26.79B | 25.66B |
| Total Liabilities | 60.66B | 55.30B | 54.71B | 61.53B | 56.06B | 54.90B |
| Stockholders Equity | 35.90B | 41.44B | 35.55B | 30.99B | 25.93B | 23.84B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.21B | 1.02B | 1.39B | -366.00M | -1.72B |
| Operating Cash Flow | 0.00 | 2.58B | 2.72B | 2.01B | 682.00M | -602.00M |
| Investing Cash Flow | 0.00 | -1.26B | -417.00M | -1.20B | -936.00M | -1.35B |
| Financing Cash Flow | 0.00 | -2.74B | -1.94B | -1.11B | 399.00M | 2.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥60.10B | 8.50 | ― | 2.44% | 3.38% | 57.67% | |
70 Outperform | ¥65.54B | 19.80 | ― | 3.98% | 0.60% | -6.50% | |
69 Neutral | ¥21.63B | 4.05 | ― | 2.46% | 3.88% | 18.72% | |
63 Neutral | ¥69.85B | 22.50 | ― | 0.34% | 10.22% | 13.91% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
56 Neutral | ¥89.31B | 10.54 | ― | 3.59% | 6.25% | 246.08% | |
50 Neutral | ¥4.27B | 196.18 | ― | 1.00% | 4.10% | -22.64% |